ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB)

CUSIP: 032724106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
28,662,716
Total 13F shares
27,945,751
Share change
-1,431,264
Total reported value
$600,836,464
Put/Call ratio
35%
Price per share
$21.50
Number of holders
129
Value change
-$16,682,226
Number of buys
55
Number of sells
58

Security key

032724106

Report period

Q4 2020

Institutions

129

Top holders

10

Top shareholders of ANAB - ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
EcoR1 Capital, LLC
13F
Company
11%
3,223,324
$47,544,000 30 Sep 2020
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
9.2%
2,628,678
$38,773,000 30 Sep 2020
13F
FRAZIER MANAGEMENT LLC
13F
Company
8.1%
2,316,447
$34,168,000 30 Sep 2020
13F
VANGUARD GROUP INC
13F
Company
7.2%
2,064,077
$30,445,000 30 Sep 2020
13F
BlackRock Finance, Inc.
13F
Company
6.7%
1,930,420
$28,473,000 30 Sep 2020
13F
Aquilo Capital Management, LLC
13F
Company
5.2%
1,477,652
$21,795,000 30 Sep 2020
13F
FEDERATED HERMES, INC.
13F
Company
4.9%
1,406,033
$20,739,000 30 Sep 2020
13F
Boxer Capital, LLC
13F
Company
4.5%
1,300,000
$19,175,000 30 Sep 2020
13F
BVF INC/IL
13F
Company
4.3%
1,227,405
$18,104,000 30 Sep 2020
13F
STATE STREET CORP
13F
Company
4.2%
1,193,596
$17,606,000 30 Sep 2020
13F
CITADEL ADVISORS LLC
13F
Company
3.3%
954,362
$14,077,000 30 Sep 2020
13F
Cormorant Asset Management, LP
13F
Company
2.3%
650,000
$9,588,000 30 Sep 2020
13F
D. E. Shaw & Co., Inc.
13F
Company
2.2%
640,946
$9,454,000 30 Sep 2020
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2%
572,727
$8,448,000 30 Sep 2020
13F
Sessa Capital IM, L.P.
13F
Company
1.8%
527,404
$7,779,000 30 Sep 2020
13F
BAKER BROS. ADVISORS LP
13F
Company
1.7%
487,243
$7,187,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
375,757
$5,542,000 30 Sep 2020
13F
Palo Alto Investors LP
13F
Company
1.3%
368,722
$5,439,000 30 Sep 2020
13F
Burrage Capital Management LLC
13F
Company
1.2%
330,549
$4,876,000 30 Sep 2020
13F
Rock Springs Capital Management LP
13F
Company
1.1%
309,113
$4,559,000 30 Sep 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1%
288,164
$4,250,000 30 Sep 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.97%
277,900
$4,099,000 30 Sep 2020
13F
NORTHERN TRUST CORP
13F
Company
0.95%
272,346
$4,018,000 30 Sep 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.94%
268,113
$3,955,000 30 Sep 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.92%
263,691
$3,889,000 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.9%
257,656
$3,790,000 30 Sep 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.79%
225,604
$3,327,000 30 Sep 2020
13F
FMR LLC
13F
Company
0.74%
213,514
$3,150,000 30 Sep 2020
13F
ORBIMED ADVISORS LLC
13F
Company
0.63%
180,442
$2,662,000 30 Sep 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.55%
156,315
$2,306,000 30 Sep 2020
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.5%
142,323
$2,099,000 30 Sep 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.49%
141,333
$2,085,000 30 Sep 2020
13F
Krensavage Asset Management, LLC
13F
Company
0.41%
118,858
$1,753,000 30 Sep 2020
13F
AXA S.A.
13F
Company
0.4%
115,800
$1,708,000 30 Sep 2020
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
0.4%
115,600
$1,705,000 30 Sep 2020
13F
Man Group plc
13F
Company
0.39%
110,883
$1,636,000 30 Sep 2020
13F
Bank of New York Mellon Corp
13F
Company
0.37%
105,730
$1,559,000 30 Sep 2020
13F
SG Americas Securities, LLC
13F
Company
0.35%
100,020
$1,475,000 30 Sep 2020
13F
MACQUARIE GROUP LTD
13F
Company
0.33%
94,428
$1,393,000 30 Sep 2020
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.31%
87,451
$1,290,000 30 Sep 2020
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.28%
81,117
$1,197,000 30 Sep 2020
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.25%
70,851
$1,045,000 30 Sep 2020
13F
PDT Partners, LLC
13F
Company
0.22%
64,253
$948,000 30 Sep 2020
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.22%
64,037
$945,000 30 Sep 2020
13F
K2 PRINCIPAL FUND, L.P.
13F
Company
0.2%
57,721
$851,000 30 Sep 2020
13F
Swiss National Bank
13F
Company
0.19%
54,600
$805,000 30 Sep 2020
13F
ALGERT GLOBAL LLC
13F
Company
0.18%
51,940
$766,000 30 Sep 2020
13F
Ikarian Capital, LLC
13F
Company
0.17%
50,000
$738,000 30 Sep 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.17%
48,486
$715,000 30 Sep 2020
13F
CREDIT SUISSE AG/
13F
Company
0.16%
45,614
$673,000 30 Sep 2020
13F

Institutional Holders of ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) as of Q4 2020

As of 31 Dec 2020, ANAPTYSBIO, INC - Common Stock, par value $0.001 per share (ANAB) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,945,751 shares. The largest 10 holders included EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Inc., FEDERATED HERMES, INC., BOXER CAPITAL, LLC, Aquilo Capital Management, LLC, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, and FRAZIER MANAGEMENT LLC. This page lists 129 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
127
Q4 2020 holders
129
Holder diff
2
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .